1 patient evaluation for Epilepsy Phase 3 Study Retigabine IR

Sort by: Most recent

Jan 16, 2011 (Started Jan 09, 2000)

  • Effectiveness
    Major (for epilepsy)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 900 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Aug 20, 2010 (Started Jan 09, 2000)

  • Effectiveness
    Major (for epilepsy)
  • Side effects
    Moderate
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 900 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Epilepsy Phase 3 Study Retigabine IR
See more data on Epilepsy Phase 3 Study Retigabine IR